DCGI approves Covaxin, Covishield Vaccine For Restricted Use In India


New Delhi: In a major development, the Drug Controller General of India (DCGI) has approved the two vaccines, Oxford-AstraZeneca Covishield and Bharat Biotech’s Covaxin, for restricted use in India.

The DCGI addressed a press conference at 11 am today at the National Media Centre regarding the Covid-19 vaccine in India.

This comes as the country moves a step closer to getting a vaccine against the novel coronavirus as two candidates — Hyderabad-based Bharat Biotech’s Covaxin and the Serum Institute of India’s Covishield — have been recommended by a government-appointed panel to the DCGI for emergency use in the last two days.

Comments are closed.

Breaking News